2015
DOI: 10.1016/j.rpsmen.2015.05.003
|View full text |Cite
|
Sign up to set email alerts
|

Executive dysfunction in schizophrenia and its association with mentalizing abilities

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
6
0
1

Year Published

2016
2016
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 23 publications
0
6
0
1
Order By: Relevance
“…In our study, it was determined that Eyes test score had a significant negative relationship with WCST perseverative error score, a significantly positive correlation with WCST categories achieved score and that cognitive flexibility level predicted better performance at the Eyes test in patients with schizophrenia. Since studies demonstrating that ToM and executive functions are impaired independent of each other (34), it is also indicated that impairment of ToM abilities cannot be explained just by lower intelligence levels and may be related with impairment of cognitive functions (14,15,35). In some of the studies that report impairment in ToM functions independent of cognitive functions in patients with schizophrenia, it is put forward that ToM functions are executed by special modules specific to this function (14,15).…”
Section: Discussionmentioning
confidence: 99%
“…In our study, it was determined that Eyes test score had a significant negative relationship with WCST perseverative error score, a significantly positive correlation with WCST categories achieved score and that cognitive flexibility level predicted better performance at the Eyes test in patients with schizophrenia. Since studies demonstrating that ToM and executive functions are impaired independent of each other (34), it is also indicated that impairment of ToM abilities cannot be explained just by lower intelligence levels and may be related with impairment of cognitive functions (14,15,35). In some of the studies that report impairment in ToM functions independent of cognitive functions in patients with schizophrenia, it is put forward that ToM functions are executed by special modules specific to this function (14,15).…”
Section: Discussionmentioning
confidence: 99%
“…Also, cognitive performance and brain volumes in SZH were contrasted against an age- and gender-matched control group to contextualise the findings: as expected, SZH had poorer cognitive performance across all domains and lower grey matter volume within most of the ROIs. Impaired neurocognitive performance 2 10 and reduced grey matter volume in fronto-temporal regions 46 50 are reliably reported in the literature.…”
Section: Discussionmentioning
confidence: 81%
“…Persistent impairments in cognitive performance are detectable in most patients with schizophrenia (SZH) and have important consequences for functional capacity 1 . Cognitive deficits span most neurocognitive domains, including attention 2 , 3 , working memory 4 , 5 , episodic memory 6 , 7 and executive function 8 10 . Cognitive deficits have also been observed in first-episode patients, suggesting they are not due to drug treatment 11 , 12 ; indeed, cognitive impairments are largely unimproved by pharmacological therapy 13 .…”
Section: Introductionmentioning
confidence: 99%
“…Executive and attentional dysfunction are common in a wide variety of conditions including acquired brain injury (e.g., TBI: Caeyenberghs et al, 2014;Cicerone & Giacino, 1992;McDonald, Flashman, & Saykin, 2002;Shah et al, 2017;Tramontana, Cowan, Zald, Prokop, & Guillamondegui, 2014), stroke (Olgiati, Russell, Soto, & Malhotra, 2016;Pohjasvaara et al, 2002;Vataja et al, 2003), neuropsychiatric (e.g., bipolar depression: Caixeta et al, 2017;and schizophrenia: Carter et al, 2010;Dirnberger, Fuller, Frith, & Jahanshahi, 2014;Gavilán & García-Albea, 2015), neurodegenerative (e.g., Alzheimer's disease: Amiéva et al, 2004;Binetti et al, 1996;Firbank et al, 2016;Moreira, Lima, Vicente, 2014;Moreira, Costa, Machado, Castro, Lima, & Vicente, 2019;Swanberg, Tractenberg, Mohs, Thal, & Cummings, 2004; the behavioral-variant frontotemporal dementia, bvFTD: Fiorentino et al, 2013;Slachevsky et al, 2004;and Parkinson's: Dirnberger & Jahanshahi, 2013;Lima, Meireles, Fonseca, Castro, & Garret, 2008;Papagno & Trojano, 2018;Zgaljardic et al, 2006), and neurodevelopmental disorders (e.g., ADHD: Kingdon, Cardoso, & McGrath, 2016;Margari et al, 2016;Veloso, Vicente, & Filipe, 2020;and autism: Filipe, Frota, & Vicente, 2019;Miller & Hinshaw, 2015), among many others conditions.…”
Section: Introductionmentioning
confidence: 99%